Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Quantum Hi-Tech Pharmaceutical Technology is a specialized research and development subsidiary of ChemPartner, a leading global Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO). The company provides a comprehensive suite of integrated drug discovery services, including medicinal chemistry, biology, pharmacology, and DMPK. Based in Beijing, it serves as a critical hub for high-end pharmaceutical technology research, supporting international biotech and pharmaceutical clients in their efforts to identify and optimize novel therapeutic candidates. The company's expertise spans multiple modalities, including small molecules and biologics, with a strong focus on oncology, immunology, and neuroscience. By leveraging advanced technology platforms and a highly experienced scientific team, it helps accelerate the transition of drug candidates from the laboratory to clinical development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Quantum Hi Tech Pharmaceutical Technology.